LIFECORE BIOMEDICAL, INC. Acquisitions, Net of Cash Acquired
LIFECORE BIOMEDICAL, INC. (LFCR) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2021-05-30, per its 10-K filed 2021-07-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2021-07-29
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2020-05-31 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-05-26 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, net of cash acquired for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, net of cash acquired for fiscal 2019 was $59.87M.
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, net of cash acquired for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|
| 2021-05-30 | $0.00 10-K · filed 2021-07-29 | ||
| 2020-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $0.00 10-K · filed 2021-07-29 | |
| 2020-02-23 | $0.00 10-Q · filed 2020-04-03 | ||
| 2019-05-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $59.87M 10-K · filed 2021-07-29 | |
| 2019-02-24 | $59.87M 10-Q · filed 2020-04-03 | ||
| 2018-05-27 | $0.00 10-K · filed 2020-08-14 | ||
| 2017-05-28 | $2.50M 10-K · filed 2019-08-01 | ||
| 2012-05-27 | $66.83M 10-K · filed 2014-08-01 | ||
| 2010-05-30 | $39.68M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |